Securities and Exchange Commission
                              Washington, DC 20549

                                   FORM 10-KSB

              x Annual Report pursuant to Section 13 or 15(D) of th
                       e Securities Exchange Act of 1934
                                 (Fee required)
                   For the fiscal year ended December 31, 2002
                                       Or
       Transition Report pursuant to Section 13 or 15(D) of the Securities
                              Exchange Act of 1934
                                (No Fee Required)
                         Commission File Number: 0-28580

                             Triad Industries, Inc.
             (Exact Name of Registrant as specified in its charter)

                  Nevada                                  88-0422528
(State or other jurisdiction of            (IRS Employer Identification Number)
incorporation or organization)
                           350 W. 9th, Ave, Suite 104
                               Escondido, CA 92025
              (Address and zip code of principal executive offices)

                                 (760) 291-1710
              (Registrants telephone number, including area code)

        Securities registered pursuant to Section 12(b) of the Act: NONE

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant  was required to file such  reports) and (2) has been subject to such
filing requirements for the past 90 days.

                                    x YES NO
     Indicate by check mark if disclosure of delinquent  filers pursuant to Item
405 of Regulation  S-K (229.405 of this chapter) is not  contained  herein,  and
will not be contained,  to the best of the registrants knowledge, in definitive
proxy or information  statements  incorporated  by reference in Part III of this
Form 10-K or any  amendment to this Form 10-K.  x As of December  31, 2002,  the
aggregate  market  value  of the  voting  stock  held by  non-affiliates  of the
registrant  was $45,314 based upon a $.005 per share trading price on January 2,
2003.  Indicate  the number of shares  outstanding  of each of the  registrants
classes of common stock, as of the latest practicable date.
                    Common Stock             10,074,863 Shares Outstanding
                   $0.001 par value                as of December 31, 2002

                       Documents Incorporated by reference

     Certain information required by Part III of this Form 10-KSB is included by
reference to the Companys  definitive  proxy statement filed in accordance with
rule 14a-101, Schedule 14A.

Traditional Small Business Disclosure Format (check one): X Yes No

          The issuers revenues for its most recent year were $651,308.







                                       ii

                             TRIAD INDUSTRIES, INC.
                                TABLE OF CONTENTS
                                   PART I Page
Item 1.          Description of Business               2-4
Item 2.          Description of Property      4-5
Item 3.          Legal Proceedings           5-6
Item 4.          Submission of Matter to a Vote of Security Holders        6
                                                                PART II
Item 5.          Market for Common Equity and Related Stockholder
                     Matters           6-7

Item 6.          Managements Discussion and Analysis or Plan of
                     Operation           7-8

Item 7.          Financial Statements        8

Item 8.          Changes in and Disagreements with Accountants on
                      Accounting and Financial Disclosure           9

                                                               PART III

Item 9.          Directors, Executive Officers, Promoters and Control persons;
                     Compliance with Section 16(a) of the Exchange Act      9-10

Item 10.         Executive Compensation  10-11

Item 11.        Security Ownership of Certain Beneficial Owners and
                     Management       11

Item 12.        Certain Relationships and Related Transactions         12

Item 13.        Exhibits and Reports on Form 8-K                    12


SIGNATURES                 S-1


                                                                   1


ITEM     1.       Description of Business

     Triad Industries, Inc. (the Company) was incorporated under the laws of the
State  of Utah on  November  25,  1985.  The  Company  was  originally  known as
Investment   Marketing,   Inc.   Investment   Marketing,   Inc.  was  originally
incorporated for the purpose of buying,  selling,  and dealing in real property.
At a Special Meeting of the Shareholders  held June 6, 1990 the company name was
changed to Combined  Communication,  Corp. On June 7, 1990 the company completed
the merger and became a Nevada corporation. Combined Communication, Corp. was in
the business of merchandising video tapes through automated dispensing machines.
The company exited the video merchandising business by selling the merchandising
assets to ARS  International  in August of 1994.  Combined  Communications  then
managed ARS International in their merchandising  operations until October 1997.
On October 17, 1997 at a Special Meeting of the Shareholders, the company met to
amend the  Articles  of  Incorporation  to change the name of the  company to RB
Capital  &  Equities,  Inc.  On  March  15,  1999 at a  Special  Meeting  of the
Shareholders  HRM (1) reversed  its common stock on a one for  ten(1:10)  basis
from 5,256,716 to 526,672  shares  outstanding.  Also at the Special  Meeting of
Shareholders,  HRM ratified a plan of reorganization whereby Healthcare Resource
Management  would acquire 100% of the  outstanding  shares of common stock of RB
Capital and its  subsidiaries  (Gam Properties and Miramar Road  Associates) for
5,068,150  shares of HRM post split  common  stock and  700,000  shares of $1.00
preferred  stock.  (Gam  Properties and Miramar Road became  subsidiaries  of RB
Capital on  February  26,  1999.  RB Capital &  Equities  had a note  payable to
American Health  Systems,  Inc., for $1.4 million for these  subsidiaries.  This
note was  retired by  issuance  of 700,000  $1.00  preferred  shares and 373,333
shares of pre split common stock to American Health Systems,  Inc. for the above
mentioned  note.) RB Capital  and  Equities  was a  non-trading  publicly  owned
company.  The company has approximately  400 shareholders.  The only significant
shareholder  was American  Health  Systems,  Inc. who owned  373,333  (23.5%) of
common shares before the merger and 1,120,000 (17.5%) of common shares after the
merger.  The  700,000  shares of  preferred  stock that were  issued to American
Health Systems,  Inc. was for a note payable for the 99% interest RB Capital had
acquired in Miramar Road  Associates on February 28, 1999. The  acquisition  was
accounted for as a recapitalization of RB Capital because the shareholders of RB
Capital controlled HRM after the acquisition.  Therefore,  RB Capital is treated
as the acquiring entity for accounting  purposes and HRM is the surviving entity
for legal purposes. On March 15,1999 the shareholders also approved an amendment
to  the  Articles  of  Incorporation   changing  the  corporate  name  to  Triad
Industries,  Inc. In September of 1999 Triad Industries  acquired the unowned 1%
interest  in Miramar  Road  Associates,  for cash.  On June 30, 2000 the Company
issued  1,463,302  shares of common stock at $.96 per share to purchase  certain
assets,  subject to certain  liabilities of three  entities.  The Company issued
895,200 shares of common stock to Northwest Medical Clinic, Inc (an S Corp). The
Company issued 346,600 shares of common stock to Amerimed of Georgia and 221,502
shares of common stock to Florimed of Florida.  The certain  assets,  subject to
certain  liabilities  were all  acquired in separate  transactions.  The certain
assets,  subject to certain  liabilities were  simultaneously  placed in a newly
capitalized  Corporation named Northwest Medical Clinic, Inc. Although the prior
operating name was used, it should be noted that the purpose of this acquisition
was to use the  Companys  public  status to raise  funds  through the sale of
common stock to be able to inject capital into the medical clinic to change its
direction. The personal injury sector that the clinic had historically performed
was no longer a  profitable  due to several  factors.  The main factors were the
length  of  time  to  collect  on an  outstanding  balance  from  the  insurance
providers,  and the litigious nature of insurance  claims.  The operators of the
clinic had determined  that they must change the services they provided in order
to remain in business. However, the clinic did not have the access to sufficient
capital to change  direction.  The Company  determined  that they would  acquire
certain assets, subject to certain liabilities from three entities to capitalize
a medical division  balance sheet  (operating  under the name Northwest  Medical
Clinic Inc), then,  immediately  inject sufficient  capital to change the clinic
direction in order for it to be viable.  The assets  acquired in the transaction
was cash of $1,731,  equipment of $46,125 and  $1,512,850  (net of allowance for
uncollectible  accounts) in accounts receivable.  The major liabilities acquired
were notes and accounts  payable in the amount of $135,749.  1,463,302 shares of
common stock were issued at $.96 per share for a total of $1,401,018. The shares
were issued  under  Section 4(2) of the 1933  Securities  Act and were issued as
restricted  securities.  The  transaction  was  accounted  for as a purchase  in
accordance  with APB No. 16.  There were no material  relationships  between the
shareholders  of  Northwest  Medical  Clinic,  Inc.,  and  any of the  Companys
affiliates,  officers or directors.  The assets  subject to the  liabilities  of
Northwest  Medical Clinic,  Inc., were purchased from  shareholders.  On June 6,
2001 Triad acquired 100% of the  outstanding  common stock of Corporate  Capital
Formation,  Inc. a Nevada corporation,  in exchange for 900,000 shares of common
stock. The transaction was valued $96,000. In accordance with regulation SB 310,
the Company was not  required  to provide pro forma  statements  or two years of
prior audits. On January 1, 2002 Northwest Medical Clinic, Inc. was sold back to
its original  shareholders  in exchange for the common stock that was issued to
purchase  the  assets  and  liabilities.  Due  to  the  Companys  common  stock
decreasing  from $.96 per share at the time of the  acquisition,  to $.02 at the
time of the sale back, the Company  recognized a $1,542,394  loss on the sale of
this discontinued  operation. As of December 31, 2002 the Company had 10,074,863
shares of $.001 par value common stock  outstanding  and 150,000 shares of $1.00
preferred stock outstanding.

Subsidiaries

         Triad owns four subsidiaries on a wholly owned basis:

     1- RB Capital and  Equities,  Inc.,  a Nevada  corporation,  is a financial
service corporation that operates a merger and acquisition  consulting business.
The company does corporate filings and capital reorganization business for small
emerging private and public client corporations. 100% owned.

     2- Miramar Road Associates,  LLC. a California  Limited Liability  Company,
The LLC. sold its only holding which was a 51,000 square foot commercial center
located at 6920 Miramar Road, San Diego,  CA 92121.  In May of 2001, the Company
closed the sale of its Miramar  property for  $3,950,000 and paid off $3,000,000
mortgage debt on the property. After paying off the mortgage debt, closing costs
and sales  commission the Company netted $488,000 from the sale of the property.
Therefore, for all intents and purposes Miramar Road and Associates is currently
inactive. 100% owned.

     3- Healthcare Resource  Management,  Inc., a Nevada corporation.  Presently
inactive.

     4- Corporate Capital Formation, Inc., a Nevada Corporation,  is a financial
services corporation that operates a merger and acquisition consulting business.
The company does corporate filings,  capital  reorganizations and resident agent
services  for small and emerging  private or public  companies.  100% owned.  It
should be noted that during the fourth quarter of 2001 the company  consolidated
Gam  Properties,  Inc.  a  subsidiary  into the  parent  holding  company  Triad
Industries,  Inc.  Therefore,  Triad  Industries  Inc.,  is no  longer a holding
company and has business  activities of its own. During 2002, Triad Industries,
Inc. sold the  residential  real estate that it had acquired from  consolidating
Gam Properties,  Inc.  However,  the Company still operates a 12,134 square foot
commercial property located at 350 W. Ninth Avenue, Escondido, CA 92025.


Services and Operations

     Triad Industries, Inc. Parent Company. Triad owns and operates a commercial
property in San Diego County California.

     350 W. Ninth Street,  Escondido,  California.  This property consists of an
12,134 square foot commercial  building.  There are a total of eleven tenants as
of December  31, 2002  including  RB Capital & Equities (a  subsidiary  of Triad
Industries, Inc.).

         RB Capital & Equities, Inc.        100% owned
     The Company is in the merger and acquisition  consulting  business.  In the
financial services area the firm prepares S-1, SB2, S-4, and S-18,  Registration
Statements,  15c2-11 filings,  Regulation D 504, 505, and 506 Private  Placement
memorandums with regulatory  filings,  and other SEC reports such as Form 10 and
Form 10SB,  8K and related  filings.  In addition the Company  prepares  Plan of
Reorganization  for Internal Revenue Code, Rule 368 (a)(1)(a),  369(a)(1)(b) and
369c  (a)(1)(c)  for  business  combinations.  The firm also  prepares and files
Articles of Incorporation, By Laws, Officer and Director filings, State reports,
business  plans,  and does  general  accounting  for client  firms.  The Company
arranges  for  independent  auditing  and legal  services  to be  performed  for
clients. The Company does not share fees with other  professionals.  The Company
functions  in  the  Public  Relations  areas  including,   but  not  limited  to
shareholder  letters,   corporate  profiles,  press  releases  based  on  client
information.

         Miramar Road Associates,LLC. 100% owned.
     California Limited Liability Company.  The LLC. sold its only holding which
was a 51,000 square foot  commercial  center  located at 6920 Miramar Road,  San
Diego,  CA 92121.  In May of 2001,  the  Company  closed the sale of its Miramar
property for $3,950,000  and paid off $3,000,000  mortgage debt on the property.
After paying off the  mortgage  debt,  closing  costs and sales  commission  the
Company  netted  $488,000  from the  sale of the  property.  Therefore,  for all
intents and purposes Miramar Road and Associates is currently inactive.


         Corporate Capital Formation, Inc. 100% owned
     The Company is in the merger and acquisition  consulting  business.  In the
financial services area the firm prepares S-1, SB2, S-4, and S-18,  Registration
Statements,  15c2-11 filings,  Regulation D 504, 505, and 506 Private  Placement
memorandums with regulatory  filings,  and other SEC reports such as Form 10 and
Form 10SB,  8K and related  filings.  In addition the Company  prepares  Plan of
Reorganization  for Internal Revenue Code, Rule 368 (a)(1)(a),  369(a)(1)(b) and
369c  (a)(1)(c)  for  business  combinations.  The firm also  prepares and files
Articles of Incorporation, By Laws, Officer and Director filings, State reports,
business  plans,  and does  general  accounting  for client  firms.  The Company
arranges  for  independent  auditing  and legal  services  to be  performed  for
clients. The Company functions in the Public Relations areas including,  but not
limited to  shareholder  letters,  corporate  profiles,  press releases based on
client  information.  The company  also  performs  resident  agent  services for
outside clients

         Healthcare Resource Management, Inc. 100% owned
     Healthcare  Resource  Management,  Inc., Inc. is a Nevada  corporation that
resulted from the business  combination of Healthcare  Resources and RB Capital.
Healthcare  Resource  Management,  Inc. is  designed to be a medical  management
company, however; it is presently inactive.

Employees

     Including its officers and directors the consolidated  operations  employ 4
full  time  employees.  There  are four full  time  employees  in the  financial
services sector (RB Capital & Equities,  Inc. and Corporate  Capital  Formation,
Inc.).  One employee from the financial  services sector handles the real estate
properties.  This  one  employee  devotes  time  on a as  needed  basis  for the
commercial real estate operation. The companies also use independent consultants
for a variety of tasks.

Item 2.  Description of Property

     Triad  Industries,   Inc.,  and  RB  Capital  &  Equities,  Inc.,  occupies
approximately  1645  square  feet of  general  office  space at 350 W. Ninth St,
Escondido,  CA 92025. Triad Industries,  Inc. owns the building. The building is
approximately  12,134 square feet, of this 10,484 is rented to others on a month
to month basis. Corporate Capital Formation,  Inc. uses a 100 square foot office
located at 2724 Otter Creek Ct. #101, Las Vegas, NV 891117, which is provided by
its  President.  The table below  illustrates  the purchase  price,  mortgages,
equity,  annualized rental income and occupancy of the commercial property owned
by Triad Industries, Inc. as of December 31, 2002.

             Purchase                  Interest        Rental
Property      Price       MortgageRate   Equity      Income

350 W. Ninth St.$1,070,000 $734,808  7.82%$335,192   $150,144   100% Occupied
11 tenants


     Five tenants: (1) Manitou Engineering, (2) RB Capital & Equities, Inc., (3)
Embience (4)  Sullivan  Construction  and (5) SCI CA Funerals  occupy 70% of the
building and contribute  67% of the rental revenue with 6 other tenants  renting
the rest of the building.  The  Balboa-Hornblend  property sold for $391,500 and
closed on January 30, 2002. The property had a cost of $386,350,  for a net gain
on the sale of the asset of $5,150.The  Grand Avenue  property sold for $350,000
and closed on March 31, 2002. The Grand Avenue  property had a cost of $261,867,
for a net gain on the sale of the asset of $88,133.  In regards to the Companys
real  estate  holdings  there  are no  limitations,  which  have been set by the
Companys  management as to any  limitations on the percentage of assets,  which
maybe invested into any one investment,  or type of investment.  This policy may
be changed without a vote of the companys shareholders. It is the intent of the
Company to acquire these properties primarily for capital  appreciation.  In the
opinion of  management,  the property the Company owns is adequately  covered by
insurance and in excellent rental
condition.

Commercial Property Held by Triad Industries, Inc.

     The company owns a twelve thousand,  one hundred and sixty four square foot
commercial  building  located at 350 West Ninth  Avenue,  San Diego,  California
92025. There are nine tenants leased on a standard  commercial basis, all others
are month to month. There are eight tenants who occupy the building. There are 5
material  tenants  that  occupy  8,557  square feet or 70% of the  building  and
contribute to 67% of the rental income per month.

         Tenant      Square Footage   Annual Rent Lease Exp. Date
Manitou Engineering             3,497   $48,192   no lease
RB Capital & Equities, Inc*     1,645         -   no lease
Embience                        1,375    21,648   9/01/03
Sullivan Construction           1,020    13,464   2/01/03
SCI CA Funerals                 1,020    16,692   7/31/03

     * RB Capital & Equities, Inc. is a subsidiary of Triad Industries,  Inc and
does not pay rent.

Projected Annual Income          $150,144
Projected Service Fees (loans)     68,316
Taxes                              13,380
Rental Rate Per Square Foot      $   1.03




                                            Mortgages

               Interest Rate   Principal    Note Due Date      Mo. Payment
First Trust Deed    7.82%      $  744,055       6/11/2026        $5,693

     Five tenants: (1) Manitou Engineering, (2) RB Capital & Equities, Inc., (3)
Embience (4)  Sullivan  Construction  and (5) SCI CA Funerals  occupy 70% of the
building and contribute  67% of the rental revenue with 6 other tenants  renting
the rest of the
building.

     The table below sets forth the lease expirations of the commercial property
for the next ten years*.

Year # of Tenants Sq. Feet Annual Rent   % of Annual Rent
2003         8     9,009   129,834        86
2004         2     1,532    20,310        14


     * Table does not include RB Capital & Equities,  Inc.  because  they do not
pay rent.  Tenants who pay month to month will be considered to have their lease
expire in the next year. Therefore, there will be ten tenants represented in the
chart  above.  In regards to the  Companies  real estate  holdings  there are no
limitations,  which  have  been  set  by  the  companys  management  as to  any
limitations  on the  percentage  of  assets  that  maybe  invested  into any one
investment, or type of investment.  This policy may be changed without a vote of
the  companys  shareholders.  It is the intent of the Company to acquire  these
properties primarily for capital appreciation.  In the opinion of management all
the properties  the Company owns are adequately  covered by insurance and are in
excellent rental condition.

     Triad Industries Inc, is not experiencing  heavy competition due to the low
commercial  vacancy  rate in San  Diego.  It should be noted  that  there are no
vacancies in the  commercial  property the Company  owns.  The Triad  Industries
building  is  depreciated.  The  federal  tax  basis  for this  depreciation  is
$1,070,000,  the federal tax rate for depreciation is .017, and the depreciation
method used is MACRS (Modified  Accelerated  Cost Recovery  System).  The useful
life of the property is deemed to be 31.5 years for tax purposes.


Item 3.  Legal Proceedings

     The Company is not a part of any material pending legal  proceedings and no
such  action by, or to the best of its  knowledge,  against the Company has been
threatened.

Item 4.  Submission of Matters to Vote of Security Holders

         There were no matters voted on this year by the shareholders.

                                                                Part II

Item 5.  Market for Registrants Common Equity and Related Matters

     The  Companies  common stock is traded in the NASD  Electronic  Pink Sheets
under the symbol  TRDD.  The  company  stock has,  during the fiscal year ending
December 31, 2002, traded between $.005 and $.08 per share. The number of shares
of record of common stock,  $.001 par value, of the Company was 10,074,863 as of
December 31, 2002. The Company has not yet adopted any policy regarding  payment
of  dividends.  It should be noted  that the  Company  declared a one for twenty
stock split, which was effective on February 28, 2003.
     The high and low bid price  quotations  for the common  stock,  as reported
NASDAQ are as follows for the periods indicated:

                            Low              High
Qtr Ended 3-31-00          $.09             $.30
Qtr Ended 6-30-00          $.01             $.09
Qtr Ended 9-30-00          $.01             $.09
Qtr Ended 12-31-00         $.01             $.06
Qtr Ended 3-31-01          $.005            $.02
Qtr Ended 6-30-01          $.01             $.08
Qtr Ended 9-30-01          $.01             $ 03
Qtr Ended 12-31-01         $.005            $.03

     As of December 31, 2002, the Company has issued and outstanding  10,074,863
shares of common stock  outstanding to 499 shareholders of record,  which figure
does not take into account those  shareholders  whose certificates that are held
in the name of broker-dealers. The ability of an individual shareholder to trade
their  shares  in a  particular  state  may be  subject  to  various  rules  and
regulations  of that  state.  A  number  of  states  require  that  an  issuers
securities  be  registered  in  their  state  or  approximately   exempted  from
registration  before  the  securities  are  permitted  to trade  in that  state,
Presently, the Company has no plans to register its securities in any particular
state.  Further,  most likely the Common Stock will be subject to the provisions
of  Section  15(g) and Rule 15g-9 of the  Securities  Exchange  Act of 1934,  as
amended (the Exchange  Act),  commonly  referred to as the penny stock rule.
Section 15(g) sets forth certain  requirements  for  transactions in penny stock
and Rule 15g-9 (d)(1) incorporates the definition of penny stock as that term is
used in Rule 3a51-1 of the Exchange Act. The Securities and Exchange  Commission
(the Commission)  generally defined penny stock to be any equity security that
has a market  price less than $5.00 per  share,  subject to certain  exceptions.
Rule 3a51-1  provides that an equity  security is considered to be a penny stock
unless that security is: registered and traded on a national securities exchange
meeting specified criteria set by the Commission; authorization for quotation on
The NASDAQ Stock Market;  issued by a registered  investment  Company;  excluded
from the  definition  on the basis of price (at  least  $5.00 per  share) or the
issuers net tangible assets; or exempted from the definition by the Commission.
If the Companys shares are deemed to be penny stock, trading in the shares will
be subject to additional sales practice  requirements on broker-dealers who sell
penny  stocks  to  persons  other  than  established  customers  and  accredited
investors,  generally  persons  with  assets in excess of  $1,000,000  or annual
income  exceeding  $200,000,   or  $300,000  together  with  their  spouse.  For
transactions   covered  by  these  rules,   broker-dealers   must  make  special
suitability  determination  for the  purchase of such  securities  and must have
received  the  purchasers  written  consent  to the  transaction  prior  to the
purchase.  Additionally,  for any  transaction  involving  penny  stock,  unless
exempt,  the rules require the delivery,  prior to the first  transaction,  of a
risk  disclosure  document  relating to the penny stock market.  A broker dealer
must also  disclose the  commissions  payable to both the broker  dealer and the
registered representative,  and current quotations for the securities.  Finally,
monthly  statements must be sent disclosing the recent price information for the
penny stock held in the account and  information  on the limited market in penny
stock and/or maintain a market in the Companys  Common Stock and may affect the
ability of shareholders to sell their shares.

         Dividends

     The Company has not declared or paid dividends or made distributions in the
past,  and the Company does not  anticipate  that it will pay cash  dividends or
make distributions in the foreseeable future.

         Recent Sales of Unregistered Securities

     On January 5, 2000 the Company  issued 72,000 shares of common stock to its
directors for services rendered at $.06 per share, for total  consideration of $
4,320.

     On March 1, 2000 the Company  issued  123,333 shares of common stock to its
president  for  services  for  services  rendered  at $.15 per share,  for total
consideration of $ 18,000.

     On June 15,  2000 the  Company  issued  72,000  shares of  common  stock to
directors for services  rendered at $.50 per share,  for total  consideration of
$36,000.

     On June 30, 2000 the Company  issued  1,463,302  shares of common  stock at
$.96 per share to purchase  certain  assets,  subject to certain  liabilities of
three  entities.  The Company issued 895,200 shares of common stock to Northwest
Medical  Clinic,  Inc (an S Corp).  The Company  issued 346,600 shares of common
stock to Amerimed of Georgia and 221,502  shares of common  stock to Florimed of
Florida. Total consideration received was $1,401,018.

     On June 30, 2000 the Company also issued  36,583  shares of common stock at
$.96 per  share,  to Donner  Investment  Corp.  as a  finders  fee for the above
transaction. Total consideration paid was $35,120.

     On October 1, 2000,  200,000  shares of common  stock were  issued to Novak
Capital  Corporation as fees for Investor  Relations  Services.  The shares were
issued at $.20 per share, for total consideration of $40,000.

On December 12, 2000 the Company issued 288,000 shares to officers and
directors for services  rendered at $.24 per share,  for total  consideration of
$67,680.  .

On January 15, 2001 the Company issued 50,000 shares of common stock
to 5 employees of Northwest Medical Clinic under the Companys Gross Annual Wage
Bonus Plan at $.17 per share, for total  consideration of $4,320.

     On January 18, 2001 the Company  issued  144,762  shares of common stock to
eight employees of the Company for services  accrued in the amount of $30,324 as
of the year ended 2000 at $.21 per share.

On February  21, 2001 the Company  issued  25,100  shares of common  stock to an
employee  for  services  rendered at $.17 per share and total  consideration  of
$3,740.

     On March 1, 2001,  the Company  issued 700,000 shares to management and key
employees under the Companys employee stock options plan. The shares were issued
at $.17 per  share  and a stock  subscription  receivable  was  recorded  on the
Companys books in the amount of $119,000.

     On June 6, 2001 the Company  issued  900,000 shares of common stock at $.11
per share in exchange  for 100% of the shares of  Corporate  Capital  Formation,
Inc. and total consideration of $96,000.

     On June 22,  2001  the  Company  issued  360,000  shares  of  common  stock
collectively to directors shares to directors for services  rendered at $.03 per
share for services rendered in the amount of $10,800.

     On, October 1, 2001 the company retired the stock  subscription  receivable
that was issued on March 1, 2001.  The  700,000  shares  that were  issued  were
cancelled and the stock subscription receivable was retired.

     On January 1, 2002  Northwest  Medical  Clinic,  Inc.  was sold back to its
original  shareholders in exchange for the 1,463,302 shares of common stock that
was issued to purchase the assets and  liabilities.  Due to the Companys  common
stock decreasing from $.96 per share at the time of the acquisition,  to $.02 at
the time of the sale back, the Company  recognized a $1,542,394 loss on the sale
of this discontinued operation.

     On October 15, 2002 American  Health Systems,  Inc.  converted on a two for
one basis 700,000 shares of preferred stock it had held. Therefore,  the Company
issued 1,400,000  shares of common stock for this  conversion.  All of the above
issued shares were issued in accordance with section 4(2) of the 1933 Securities
Act
and bear a restrictive  legend.

     As of December  31, 2002 the  Company has a total of  10,074,863  shares of
common stock outstanding. It should be noted that the Company declared a one for
twenty stock split, which was effective on February 28, 2003.

Description of Securities

     All shares of Common  Stock have equal rights and  privileges  with respect
voting  liquidation and dividend rights.  All shares of Common Stock entitle the
holder thereof to (i) one  non-cumulative  vote for each share held of record on
all matters submitted to a vote of the stockholders; (ii) to participate equally
and to receive  any and all such  dividends  as may be  declared by the Board of
Directors out of funds legally available therefore; and (iii) to participate pro
rata in any distribution of assets  available for distribution  upon liquidation
of the Company. Stockholders of the Company have no preemptive rights to acquire
additional shares of Common Stock or any other  securities.  The Common Stock is
not subject to redemption and carries no subscription or conversion  rights. All
outstanding shares of Common Stock are fully paid and non-assessable.  There are
no provisions in Triad Industries,  Inc.,  charter or bylaws that would prevent,
delay or  defer a change  in  control.  As of  December  31,2002,  there  are no
warrants  outstanding.  The only  convertible  securities  that are  outstanding
consist of 150,000  shares of preferred  stock,  which  convert on a two for one
basis. It should be noted that in conjunction  with the Companys one for twenty
reversal,  after February 28, 2003,  there will be only 7,500  preferred  shares
outstanding.  No common  stock has been  proposed to be offered  publicly by the
Company.  The preferred  stock is (1) non- voting stock,  (2) convertible at the
second  anniversary  from issuance on a two for one (2:1) basis to common stock,
(3)  has a  preference  over  common  stock  to be paid  $1.00  per  share  as a
preferential liquidation.





Dividend Policy

     The Company has not declared or paid dividends or made distributions in the
past,  and the Company does not  anticipate  that it will pay cash  dividends or
make distributions in the foreseeable future.

Item 6.  Managements Discussion and Analysis or Plan of Operation

     The following  discussion pertains to the Companys results of operations as
of the years ended  December  31, 2002 and 2001.  The Company  consolidates  the
operations of RB Capital and Equities, Inc., Corporate Capital Formation,  Inc.,
(financial services sector), and Triad Industries, Inc. (real estate sector). On
January 1, 2002 Northwest  Medical  Clinic,  Inc. was sold back to its original
shareholders  in exchange  for the common  stock that was issued to purchase the
assets and  liabilities.  Due to the Companys common stock decreasing from $.96
per share at the time of the acquisition,  to $.02 at the time of the sale back,
the  Company  recognized  a  $1,542,394  loss on the  sale of this  discontinued
operation. Triad Industries,  Inc. operates the commercial building. Overall the
real estate sector 100%  occupancy from its  commercial  property.  RB Capital &
Equities  Inc, and  Corporate  Capital  Formations,  inc. had weak revenues when
compared to the prior year.  Management  attributes this to a further  softening
stock market and investors  looking for more secure  investments  than equities.
This affects RB Capital & Equities, Inc. and Corporate Capital Formations,  Inc.
greatly,  due to the fact that the Company derives its revenues from performing
consulting  work for companies that wish to soon trade publicly and derive their
operating  capital  from  public  investment.  In the opinion of  management,  a
downtrodden stock market, a decrease in initial public offerings, and the public
keeping  their money out of equities  all had a negative  affect on RB Capital &
Equities, Inc. The Company does not expect to purchase any significant equipment
during the next twelve  months.  Management  does not intend to hire  additional
employees;  the only  hiring  would be to  replace a vacated  position.  In such
cases,  compensation  to  management  and  employees  will  be  consistent  with
prevailing wages for services rendered.



Results of Operations

     Revenues totaled $651,308 as of December 31, 2002 compared to $1,950,308 as
of December 31, 2001; this is a decrease of approximately  67%. The decrease can
largely  be  explained  by the sale  back of  Northwest  Medical  Clinic,  Inc.,
Amerimed,  and Florimed.  The sale of the last two residential rental properties
the  Company  held  during  the first  quarter of 2002 also  attributed  to this
decrease.  Further  contributing  to the  decrease  in  revenues  was  the  poor
performance of the financial services sector.

         Revenue for the years ended December 31, 2002 and 2001 by sectors

                                               2002            2001

RB Capital                                   $  400,645   $  502,561
Miramar Road                            **            -      218,818
Northwest Medical*                                    -    1,077,210
Corporate Capital Formation                      64,760       63,250
Triad Industries, Inc.                          185,905       88,470

     *Triad  Industries,  Inc. sold Northwest Medical Clinic January 1, 2002. **
Miramar Road Associates sold their commercial building in May of 2001.

     For the year ended  December  31,  2002 the  Company  had net  income  from
continuing operations of $137,593 compared net income from continuing operations
of  $56,249  for the same  period  of 2001.  The  Company  did have a loss  from
discontinued operations of $1,542,394. This was due to Northwest Medical Clinic,
Inc.  being sold back to its  original  shareholders  in exchange for the common
stock  that was  issued to  purchase  the  assets  and  liabilities.  Due to the
Companys  common  stock  decreasing  from  $.96  per  share  at the time of the
acquisition,  to $.02 at the time of the sale back,  the  Company  recognized  a
$1,542,394 loss on the sale of this discontinued  operation.  For the year ended
December  31,  2002 the  Company  had a net loss of  $1,404,801  compared to net
income of $56,249 for the same period the year before. Revenues totaled $651,308
as of December 31, 2002 compared to $1,950,308 as of December 31, 2001;  this is
a decrease of  approximately  67%.  The decrease can largely be explained by the
sale back of Northwest Medical Clinic, Inc., Amerimed, and Florimed. The sale of
the last two  residential  rental  properties  the Company held during the first
quarter of 2002 also  attributed to this decrease.  Further  contributing to the
decrease in revenues was the poor performance of the financial  services sector.
The major factor contributing to the drop in revenues for the financial services
sector was the amount of common stock received for services.  For the year ended
December 31, 2002 the Company  recognized  $150,000 in common stock received for
services,  compared to $365,916 for the same period the year  before.  Corporate
Capital Formation, had revenues comparable to the year before. However, in 2001,
the Company  owned  Corporate  Capital for only six  months.  Corporate  Capital
Formation Inc.,  attributes the lack of revenues do to weak financial markets. A
large  majority of Corporate  Capital  Formations,  Inc.  clients rely on public
funding to operate, due to poor economic conditions public funding was difficult
to come by for their clients.  Rental revenues  dropped $168,526 due to the sale
of the  Miramar  Road  property  and  purchasing  a smaller  building  with less
rentable square footage.  The sale of the last two residential rental properties
the  Company  held  during  the first  quarter of 2002 also  attributed  to this
decrease.  The decrease in the net  operating  loss can be attributed to several
factors.  There was a $40,506 decrease in Depreciation and  Amortization,  which
can  mostly  again be  attributed  to the  Miramar  Road  sale  which was on the
Companys  books for about half of last year.  The Company also had gains on the
sale of assets in the amount of $93,283 for the year ended  December  31,  2002.
The Balboa-Hornblend  property sold for $391,500 and closed on January 30, 2002.
The property had a cost of $386,350,  for a net gain on the sale of the asset of
$5,150.  The Grand  Avenue  property  sold for  $350,000 and closed on March 31,
2002.  The Grand Avenue  property had a cost of $261,867,  for a net gain on the
sale of the  asset  of  $88,133.  General  and  Administrative  costs  decreased
$1,172,875 from 2001 to 2002 mostly due to the sale of Northwest Medical Clinic,
Inc. It should be noted that costs of sales and general and administrative costs
decreased  proportionately  to the  Companys  decreased  revenues.  The Company
realized a gain of $106,366 from the sale of  securities  compared to $27,703 in
the prior  year.  Management  does not  attribute  this  increase  to any single
factor, except that for the year ended December 31, 2001 was substantially lower
than in past years.  Bad Debt also  decreased  significantly  from  $545,638 for
fiscal 2001 to $55,504 for fiscal 2002.  The reason for the decrease in bad debt
expense is due to the nature of the  services  performed  by  Northwest  Medical
Clinic,  which was sold on January 1, 2002. Interest expense also decreased from
$192,786  for the year ended  December  31,  2001 to $75,758  for the year ended
December 31, 2002.  This can also be attributed to the Miramar Road Sale and the
disposition of the residential real estate properties.

                                                       Income Statement Summary
                                                              December 31

                                     2002     2001

Revenues                           651,308   1,950,308

Total Operating Costs              537,832   2,314,566

Income (Loss)from Operation        113,476    (364,258)

Other Income/ (Expense)             84,800     432,590

Net Gain / (Loss) Before Taxes     198,276      68,332







                        FINANCIAL INFORMATION RELATING TO
                        INDUSTRY SEGEMENTS AND CLASSES OF
                              PRODUCTS OR SERVICES

                                                          YEAR
                                            2000          2001            2002
Sales to unaffiliated customers:
Miramar Road Associates, LLC. * /
Triad Industries, Inc.
Commercial Real Estate Rental Revenue       593,483       235,008       130,662
Gam Properties, Inc.                                                          *
Residential Real Estate Rental Revenue      116,069        71,880         7,700
RB Capital and Equities, Inc. /
Corporate Capital Formation, Inc.
Financial Service Revenue                   423,405       566,211       512,946
HRM / Northwest Medical**
Healthcare Revenue (HRM inactive)           650,717     1,077,209             -

Intersegment Sales
Miramar Road Associates, LLC.                     -             -             -
Gam Properties, Inc.                              -             -             -
RB Capital and Equities, Inc.                     -             -             -
Triad Industries, Inc.                            -             -             -
HRM                                               -             -             -
Northwest Medical Clinic, Inc.                    -             -             -
Corporate Capital Formation, Inc.

Operating Profit/Loss
Miramar Road Associates, LLC.               211,861      (622,364)            -
Gam Properties, Inc.                         15,257             -             -
RB Capital and Equities, Inc.               (64,598)     (275,909)      161,846
Triad Industries, Inc.                     (218,492)     (117,606)      (32,909)
HRM                                            (355)            -             -
Northwest Medical                           (21,831)      128,263             -
Corporate Capital Formation, Inc.                 -       (28,460)      (15,462)

Identifiable Assets
Miramar Road Associates, LLC.             3,783,450             -             -
Gam Properties, Inc.                      1,035,299             -             -
RB Capital and Equities, Inc.               582,973       804,334       190,611
Triad Industries, Inc.                      601,522     2,760,124     1,949,965
HRM                                           3,026         3,026         3,028
Northwest Medial Clinic, Inc.             1,632,711     1,697,909             -
Corporate Capital Formation, Inc.                 -       170,178       113,525


*        Miramar Road Associates sold their commercial building in May of 2001.
**       Triad sold the last two residential properties it owned in the first
quarter of 2002.
***      Northwest Medical Clinic, Inc. sold on January 1, 2002.
****     Corporate Capital Formation, Inc. was acquired on June 6, 2001.


     RB Capital and Equities,  Inc. had an operating profit of $161,846 compared
to an  operating  profit of  $275,909.  There was an decrease  of  approximately
$102,000 in consulting  revenues from this financial  services  subsidiary.  The
main  contributing  factor was for the year ended  December 31, 2002 the Company
recognized $150,000 in common stock received for services,  compared to $365,916
for the same period the year before. Rental expense decreased $23,016 due to the
Company using office space  provided by Triad  Industries,  Inc.  Salary expense
also  decreased  by about  $104,580.  This is due to the  Company  further  down
sizing, due to a down economy.  However,  in comparison  operating costs for the
most part remained constant except for those disclosed above.  Corporate Capital
Formation, Inc, had a net operating loss of $15,462, compared to a net operating
loss of $28,460 for the year before.  Corporate  Capital  Formation,  Inc.,  had
revenues  comparable  to the year before.  However,  in 2001,  the Company owned
Corporate  Capital  for only  six  months.  Corporate  Capital  Formation  Inc.,
attributes the lack of revenues do to weak financial  markets.  A large majority
of Corporate Capital Formations, Inc. clients rely on public funding to operate,
due to poor  economic  conditions  public  funding was  difficult to come by for
their clients.  In conjunction with revenue being approximately half of the year
before,  operating expenses also followed the same trend. Salary expense was the
only material item to change in comparison of Corporate Capital Formation,  Inc.
general and  administrative  expenses.  Salary expense  decreased  approximately
$50,000 when  comparing  December 31,  2002,  to the same period of 2001.  Triad
Industries,  Inc. the parent company had an operating loss of $(32,909) compares
to an operating  loss of ($117,606) for the same period of 2001. It is difficult
to present comparative information for Triad Industries, Inc. This is due to the
fact that the main  operation of the parent Company is the 350 West Ninth Avenue
building,  which was acquired in the middle of 2001. The operating  costs of the
building  are for the most part  fixed,  except  for  miscellaneous  maintenance
items,  which occur from time to time.  Triad  Industries,  Inc. did have higher
revenues due to having the  commercial  property  holding for the entire year of
2002 when  compared  to 2001.  Administrative  and  general  costs of the parent
company have also remained fairly steady in terms of year to year comparison.



Recent Accounting Pronouncements

     SFAS No. 145 -- On April 30, 2002,  the FASB issued FASB  Statement No. 145
(SFAS 145),  Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB
Statement  No. 13,  and  Technical  Corrections.  SFAS 145  rescinds  both FASB
Statement No. 4 (SFAS 4),  Reporting  Gains and Losses from  Extinguishment  of
Debt,  and  the  amendment  to  SFAS  4,  FASB  Statement  No.  64  (SFAS  64),
Extinguishments  of Debt Made to Satisfy  Sinking-Fund  Requirements.  Through
this  rescission,  SFAS 145 eliminates the  requirement (in both SFAS 4 and SFAS
64) that gains and losses from the  extinguishment of debt be aggregated and, if
material,  classified as an  extraordinary  item,  net of the related income tax
effect.  However,  an entity is not prohibited from  classifying  such gains and
losses as extraordinary  items, so long as it meets the criteria in paragraph 20
of  Accounting  Principles  Board  Opinion  No.  30,  Reporting  the  Results of
Operations  Reporting  the Effects of  Disposal of a Segment of a Business,  and
Extraordinary,  Unusual  and  Infrequently  Occurring  Events and  Transactions.
Further,  SFAS 145 amends paragraph 14(a) of FASB Statement No. 13,  Accounting
for  Leases,   to  eliminate  an  inconsistency   between  the  accounting  for
sale-leaseback  transactions and certain lease  modifications that have economic
effects that are similar to sale-leaseback transactions.  The amendment requires
that a lease  modification (1) results in recognition of the gain or loss in the
9 financial statements, (2) is subject to FASB Statement No. 66, Accounting for
Sales of Real  Estate, if the leased asset is real estate  (including  integral
equipment),  and (3) is subject (in its entirety) to the sale-leaseback rules of
FASB  Statement  No. 98,  Accounting  for Leases:  Sale-Leaseback  Transactions
Involving Real Estate, Sales-Type Leases of Real Estate, Definition of the Lease
Term, and Initial Direct Costs of Direct Financing Leases.  Generally,  FAS 145
is effective for transactions  occurring after May 15, 2002. The  implementation
of SFAS 145 did not have a material effect on the financial statements.

     SFAS No. 146 -- In June 2002, the FASB issued SFAS No. 146, "Accounting for
Exit or Disposal  Activities" (SFAS 146). SFAS 146 addresses  significant issues
regarding  the  recognition,  measurement,  and  reporting  of  costs  that  are
associated with exit and disposal activities, including restructuring activities
that are currently accounted for under EITF No. 94-3, "Liability Recognition for
Certain  Employee  Termination  Benefits  and  Other  Costs to Exit an  Activity
(including  Certain Costs Incurred in a  Restructuring)."  The scope of SFAS 146
also  includes  costs  related to  terminating  a contract that is not a capital
lease and termination  benefits that employees who are involuntarily  terminated
receive under the terms of a one-time benefit arrangement that is not an ongoing
benefit arrangement or an individual  deferred-compensation  contract.  SFAS 146
will be  effective  for exit or disposal  activities  that are  initiated  after
December 31, 2002 and early  application is  encouraged.  The provisions of EITF
No. 94-3 shall  continue to apply for an exit activity  initiated  under an exit
plan that met the  criteria of EITF No. 94-3 prior to the  adoption of SFAS 146.
The effect on adoption of SFAS 146 will change on a prospective basis the timing
of when the  restructuring  charges are recorded from a commitment date approach
to when the liability is incurred. The implementation of SFAS 146 did not have a
material effect on the financial
statements.

     SFAS  No.  147 -- In  October  2002,  the FASB  issued  Statement  No.  147
Acquisitions  of  Certain  Financial   Institutions    an  amendment  of  FASB
Statements No. 72 and 144 and FASB  Interpretation  No. 9 (SFAS 147).  SFAS 147
removes acquisitions of financial  institutions from the scope of both Statement
72 and Interpretation 9 and requires that those transactions be accounted for in
accordance with FASB  Statements No. 141,  Business  Combinations,  and No. 142,
Goodwill and Other  Intangible  Assets.  Thus, the requirement in paragraph 5 of
Statement 72 to recognize  (and  subsequently  amortize)  any excess of the fair
value of  liabilities  assumed over the fair value of tangible and  identifiable
intangible  assets  acquired  as an  unidentifiable  intangible  asset no longer
applies to acquisitions  within the scope of this Statement.  In addition,  this
Statement  amends FASB  Statement  No. 144,  Accounting  for the  Impairment  or
Disposal   of   Long-Lived   Assets,   to   include   in  its  scope   long-term
customer-relationship  intangible  assets  of  financial  institutions  such  as
depositor- and  borrower-relationship  intangible  assets and credit  cardholder
intangible assets. Consequently, those intangible assets are subject to the same
undiscounted cash flow  recoverability  test and impairment loss recognition and
measurement  provisions that Statement 144 requires for other long-lived  assets
that  are  held  and  used.   SFAS  147  is  effective   October  1,  2002.  The
implementation  of SFAS  147 did not have a  material  effect  on the  financial
statements.

     SFAS No. 148 -- In December 2002, the FASB issued SFAS No. 148, "Accounting
for Stock-Based  Compensation -- Transition and Disclosure"(SFAS  148). SFAS 148
amends SFAS No. 123  "Accounting for  Stock-Based  Compensation"  (SFAS 123), to
provide  alternative  methods of transition  for a voluntary  change to the fair
value based method of  accounting  for  stock-based  employee  compensation.  In
addition,  SFAS 148 amends the  disclosure  requirements  of SFAS 123 to require
prominent  disclosures in both annual and interim financial statements about the
method of accounting for stock-based employee compensation and the effect of the
method  used on  reported  results.  SFAS  148 is  effective  for  fiscal  years
beginning  after  December  15,  2002.  The interim  disclosure  provisions  are
effective for financial  reports  containing  financial  statements  for interim
periods  beginning after December 15, 2002. The Company is currently  evaluating
the effect that the adoption of SFAS 148 will have on its results of  operations
and financial condition.

Inflation

     In the opinion of management,  inflation will not have a material effect on
the operations of Triad Industries Inc.

Liquidity and Capital Resources

     The Company has  approximately  a 3.5:1 current  ratio.  As of December 31,
2002 the Company has $1,003,938 in current assets compared to $3,962,052 for the
same period of 2001. For the year ended December 31, 2002 cash increased $4,189,
accounts  receivable  decreased  $362,140,  advanced expenses decreased $ 5,815,
marketable  securities  decreased  $504,158,  and assets held for sale decreased
$716,514  due to the  sale of the  last  two  residential  properties.  Accounts
receivable from the medical clinic  decreased  $1,633,083 due to the sale of the
medical  assets  and  liabilities  to its  former  owners.  Current  liabilities
decreased  from  $1,100,109 for the year ended December 31, 2001 to $300,173 for
the year ended  December 31, 2002. The major factor related to this change was a
$549,000  decrease in current notes  payable on real estate,  due to the sale of
the available for sale  properties.  The  outstanding  balance on the RB Capital
line of credit also decreased by about $23,000.  Other significant  decreases in
liabilities  included a $48,639  decrease  in  accounts  payable  and a $172,302
decrease in loans payable.


                              Balance Sheet Summary
                                   December 31

                                   2002       2001

Total Current Assets        1,003,938   3,962,052
Property (net)              1,074,900   1,077,363

Total Assets                2,257,129   5,435,571

Current Liabilities           300,173   1,100,109

Long Term Liabilities         583,898     845,159

Total Liabilities             884,071   1,945,268

Total Stockholders Equity   1,373,058   3,490,302

Total Liabilities and
Stockholders Equity         2,257,129   5,435,571

The  Company no longer has access to a credit line it had  established.  This is
due to the prior Company  president Gary DeGano leaving the Company.  Mr. DeGano
was the guarantor of the line of credit. Due to his retiring, the line of credit
was no longer available for use. However, the Company can pay down the remaining
balance over  approximately  ten years. As of December 31, 2002 there was $7,038
outstanding on this line of credit.  Triad Industries,  Inc., has $ 1,003,938 in
current assets  including $ 19,832 in cash. The Company  believes the $57,001 it
holds in marketable  securities to be very liquid. The marketable securities can
be converted to cash in under three days. The Company holds $ 82,312 in accounts
receivable.  This is also highly liquid,  however; this liquidity depends on the
party  the  amount  is due from.  Allowances  for bad debt have been made  where
appropriate.  The tax - impound  account  and income tax benefit are not liquid.
Due to the fact Triad Industries is a consolidated  parent holding company Triad
Industries,  Inc.  will use  revenues  from Miramar  Road  Associates,  LLC, Gam
Properties  and RB  Capital &  Equities  to  satisfy  Triads  short-  term cash
requirements.  In the event,  outside  funding is  necessary;  the Company  will
investigate  the  possibility of interim  financing,  either debt or equity,  to
provide  capital.  Although,   management  has  not  made  any  arrangements  or
definitive agreements, the Company would consider private funding or the private
placements of its securities and/or public offering.

Net Operating Losses

     The Company has  accumulated  $(2,393,782)  of net  operating  losses as of
December 31, 2001,  which may used to reduce taxes in future years through 2022.
The use of these  losses  to  reduce  future  income  taxes  will  depend on the
generation  of  sufficient  taxable  income prior to the  expiration  of the net
operating loss carryforwards.  In the event of certain changes in control of the
Company,  there will be a annual  limitation  on the amount of the net operating
loss  carryforwards  which can be used.  The  potential  tax  benefit of the net
operating loss  carryforwards  have been offset by a valuation  allowance of the
same  amount.  It  should  be noted  that a tax  benefit  carryforward  provides
benefits  to the  Company  when  there is net  income.  There are  uncertainties
surrounding the realization of the deferred tax asset.  The biggest  uncertainty
would stem from the Company having the ability to operate on a profitable basis.
In the opinion of management this is attainable. Management anticipates that net
income would have to increase by about  $300,000 a year during the  carryforward
period to recognize this benefit

Risk Factors and Cautionary Statements

     Forward-looking  statements  in this report are made  pursuant to the safe
harbor provisions of the Private Securities  Litigation Reform Act of 1995. The
Company  wished to advise  readers that actual  result may differ  substantially
from such forward-looking  statements,  forward-looking statements involve risks
and  uncertainties  that could cause actual  results to differ  materially  from
those expressed in or implied by the statements,  including, but not limited to,
the following: the ability of the Company to complete development of its primary
products  and its  ability  to  successfully  market  its  product  if and  when
developed and other risks detailed in the Companys periodic report filings with
the Securities and Exchange Commission.


Item 7.  Financial Statements and Supplementary Data

         See index to financial statements included herein.

Item 8.  Changes and Disagreements with Accountants on Accounting and
Financial Disclosure

         None



                                                               Part III

Item 9.  Directors, Executive Officers, Control Persons

     The  following  table sets forth  information,  to the best of the Companys
knowledge as of December 31, 2002,  with respect to each  director,  officer and
management as a group.


                                                Title of     Amount
Name                         Position             Class    of Shares  Percentage


Linda Bryson,                President           Common       573,332       5.6%
9980 Scripps Vista Way       Director
# 96
San Diego, CA 92131

Michael Kelleher             Secretary           Common       438,757         4%
32469 Angelo Drive           Director
Temecula, CA 9259

Roger Coleman Jr.*           Director             Common     450,000**      4.5%
2175 Zion Park Blvd
Springdale, UT 84747

Management as a Group                                       1,462,089        14%

Others owning more than 5%

American Health Systems, Inc.                                  350,000      3.5%
46 Corporate Park
Irvine, CA 92026

     The above  percentages  are  based on  10,074,863  shares  of common  stock
outstanding  on December  31, 2002. * the table above does not include the stock
that was issued in 2002 for officer and  director  fees that were accrued on the
Companys books and that are included in Item 10 of this report.  **Mr.  Coleman
is the President of Coleman  Capital that owns 450,000 shares of common stock of
Triad Industries, Inc.

     All directors hold office until the next annual meeting of stockholders and
until their  successors have been duly elected and qualified.  Directors will be
elected  at the  annual  meetings  to serve  for  one-year  terms.  There are no
agreements with respect to the election of directors.  Each executive officer is
appointed by and serves at the discretion of the Board of Directors. None of the
officers and/or directors of Triad Industries,  Inc are officers or directors of
any  other  publicly  traded  corporation,  nor  have any of the  affiliates  or
promoters of Triad Industries Inc. filed any bankruptcy petition, been convicted
in or been the subject of any pending  criminal  proceedings,  or the subject or
any order,  judgment,  or decree involving the violation of any state or federal
securities  laws within the past five years.  The  directors  will their time to
Triad  Industries  affairs on an as needed basis, the exact amount of which is
undetermined at this time. The business experience of each of the persons listed
above during the past five years is as follows:

         Linda M. Bryson, 44,  President / Director
     From 1996 to 2002,  Ms.  Bryson was the President of RB Capital & Equities,
Inc., a corporation  in the financial  services  field,  which is owned by Triad
Industries,  Inc.  Currently,  she is now the Vice  President  of RB  Capital  &
Equities,  Inc.  She has served on the board of Spa  International,  Inc. and is
currently the President of Escondido Capital Inc.

         Michael W. Kelleher, 28, Treasurer/ CFO/ Director
     Mr.  Kelleher  received his B.S.  degree in accounting from San Diego State
University.  He  is  currently  the  President  of  RB  Capital  &  Equities,  a
corporation in the financial services field, which is owned by Triad Industries,
Inc.

         Roger Coleman Jr., 50, Director
     Mr.  Coleman  has spent the last  twenty - five  years in the  construction
business,  framing,  finishing and  remodeling.  He also built,  opened and sold
three  restaurants in the Salt Lake City area of Utah.  Mr. Coleman  established
two  Bed and  Breakfast  Inns in  Springdale,  Utah  and  currently  resides  in
Springdale,  Utah with his wife. Mr. Coleman holds a B.A. from the University of
Utah and a M.B.A. from the University of Phoenix.

Compliance with 16(a) of the Exchange Act

     The  Securities  Exchange Act of 1934 requires all  executive  officers and
directors to report any changes in the  ownership of common stock of the Company
to the Securities & Exchange Commission and the Company. Management revising and
representations  indicate by date filing of holdings as of December  31, 2002 in
compliance to 16(a).





Item 10.  Executive Compensation

     The  following  table  shows the  amount  of all  compensation  earned  for
services in all  capacities to the Company for the last two fiscal years for the
executive officers as of December 31, 2002.

                                                      Restricted
                                                     Stock
Name                      Year    Salary    Bonus    Awards

Linda Bryson, President    2002   48,000    1,500    2,500*
Director                   2001   48,000        -    6,600

Michael Kelleher, Treas.   2002   48,000    1,500    2,500*
Director                   2001   48,000        -    6,000


Roger Coleman Jr.**        2002        -        -      500*
Director                   2001        -        -        -


     *Directors  received  $500to be a director for the year ended  December 31,
2001.  The  amount  was  accrued  on the  Companys  books  at  year  - end  and
subsequently  was retired via a common stock issuance of 50,000 shares of common
stock at $.01 to each  director.  *Officers  received $2000 to be a director for
the year ended December 31, 2001. The amount was accrued on the Companys  books
at year - end and  subsequently  was  retired  via a common  stock  issuance  0f
200,000  shares of common  stcok at $.01 to each  officer.  ** Mr.  Coleman  was
appointed as a Director, to fill a vacancy in early 2002. *Miss. Bryson received
$2,500 in restricted stock awards for the year ended December 31, 2002. $500 was
for director fees and $2000 in stock for services. *Mr. Kelleher received $2,500
in restricted  stock awards for the year ended  December 31, 2002.  $500 was for
director fees and $2,000 in stock for services.  *Mr.  Coleman  received $500 in
restricted stock awards for director fees for the year ended December 31, 2002.


Item 11.  Security Ownership of Beneficial Owners and Management

     The following  table sets forth,  as of December 31, 2002*,  based upon our
records  and  information   obtained  from  the  persons  named  below,  certain
information  concerning  beneficial ownership of our shares of Common Stock with
respect  to (I) each  person  known to own or more than 5% of our  understanding
shares of Common Stock, (II) each of our executive  officers and directors,  and
(III) all of our executive officers and directors as a group:

                                 Amount        Approximate
                               And Nature      Percentage
                              Of Beneficial    of Common
Identity                       Ownership       Stock Owned

American Health Systems, Inc.     350,000     3.5%(I)
Linda Bryson                      572,332     5.6%(II)
Michael Kelleher                  438,757     4%(II)
Roger Coleman Jr.**               450,000     4.5%(II)

Management as a Group           1,462,089   14% (III)

     * the above  table does not  include  the stock that was issued in 2002 for
officer and director fees that were accrued on the Companys  books and that are
included in Item 10 of this report.

Item 12.  Certain Relationships and Related Transactions

     On January 5, 2000 the Company  issued 72,000 shares of common stock to its
directors for services rendered at $.06 per share, for total  consideration of $
4,320. On March 1, 2000 the Company issued 123,333 shares of common stock to its
president  for  services  for  services  rendered  at $.15 per share,  for total
consideration of $ 18,000.  On June 15, 2000 the Company issued 72,000 shares of
common stock to directors  for  services  rendered at $.50 per share,  for total
consideration  of $36,000.  On June 30, 2000 the Company issued 1,463,302 shares
of common stock at $.96 per share to purchase certain assets, subject to certain
liabilities of three entities. The Company issued 895,200 shares of common stock
to Northwest  Medical  Clinic,  Inc (an S Corp).  The stock was issued to the 25
shareholders  of the Company.  The Company issued 346,600 shares of common stock
to  Amerimed  of Georgia  and  221,502  shares of common  stock to  Florimed  of
Florida.  Total consideration  received was $1,401,018.These  shares were issued
under section 4(2) of the 1933 securities act.

         Amerimed of Georgia         346,600
         Florimed of Tampa          221,502

     These are companies  purchased  that are  controlled by Mr. J. William Byrd
and Richard Furlong who each own 50 % of Amerimed and 47.5% of Florimed each and
therefore can initiate the vote on these  companies.  The shares are shown as an
indirect ownership under their names. In addition Mr. Byrd also received 188,560
shares from the business  combination.  Mr.  Furlong also  received  188,560 for
total direct and indirect holdings of 346,952 and 346,952, respectively. On June
30, 2000 the company  issued  36,583  shares at $.96 for a finders fee to Donner
Investment  Corporation  for the  Northwest  Medical  Clinic,  Inc.  and its two
affiliated  corporations  purchase.   Total  consideration  was  $35,120.  These
securities  were issued  under  section  4(2) of the 1933  securities  act. * On
January 1, 2002 Northwest  Medical  Clinic,  Inc. was sold back to its original
shareholders  in exchange  for the common  stock that was issued to purchase the
assets and  liabilities.  Due to the Companys common stock decreasing from $.96
per share at the time of the acquisition,  to $.02 at the time of the sale back,
the  Company  recognized  a  $1,542,394  loss on the  sale of this  discontinued
operation.  On December 12, 2000 the Company  issued  288,000 shares to officers
and directors for services  rendered at $.24 per share, for total  consideration
of $67,680.  . On January 15, 2001 the Company  issued  50,000  shares of common
stock to 5 employees  of Northwest  Medical  Clinic  under the  Companys  Gross
Annual Wage Bonus Plan at $.17 per share, for total  consideration of $4,320. On
January 18,  2001 the Company  issued  144,762  shares of common  stock to eight
employees of the Company for services accrued in the amount of $30,324 as of the
year ended 2000 at $.21 per share.  On  February  21,  2001 the  Company  issued
25,100  shares of common stock to an employee for services  rendered at $.17 per
share and total  consideration  of $3,740.  On March 1, 2001, the Company issued
700,000  shares to management  and key  employees  under the Companys employee
stock  options  plan.  The  shares  were  issued  at $.17 per  share and a stock
subscription  receivable  was recorded on the  Companys  books in the amount of
$119,000.  On June 6, 2001 the Company  issued 900,000 shares of common stock at
$.11  per  share  in  exchange  for  100% of the  shares  of  Corporate  Capital
Formation, Inc. and total consideration of $96,000. On June 22, 2001 the Company
issued  360,000  shares of common  stock  collectively  to  directors  shares to
directors for services  rendered at $.03 per share for services  rendered in the
amount  of  $10,800.   On,  October  1,  2001  the  company  retired  the  stock
subscription  receivable  that was issued on March 1, 2001.  The 700,000  shares
that were  issued  were  cancelled  and the stock  subscription  receivable  was
retired.  Triad Industries,  Inc. pays a management fee to RB Capital & Equities
in the amount of $7,500.00 per month.

Item 13.  Exhibits and Reports on 8-K

99.1             Section 906 Certification of Linda Bryson
99.2             Section 906 Certification of Michael Kelleher

                           List of documents filed as part of this report:
                           (a) Exhibits
1.       10SBA -March 22, 2001 filed by reference included restated financial
statements.
2.       Articles of Incorporation and By Laws filed by reference 10SB.
3.       March 31, 2000 10QSB Filed by reference
4.       June 30, 2000 10QSB filed by reference
5.       September 30, 2000 10QSB filed by reference
6.       Annual Meeting, Proxy Information and Proxy filed August 1, 2000.
(b)      Reports on Form on 8K
                               1.   filed June 30, 2000, Acquisition of
Northwest Medical Clinic with related documents
(c)      Financial Data Schedule

Item14. Controls and Procedures

         We have instituted disclosure controls and procedures designed to
ensure the timely recording, processing, summarization and reporting to our
management, including our Chief Executive Officer, of information required to be
disclosed in our reports under the Securities Exchange Act of 1934, as amended
(the "Exchange Act"). Within the 90 days prior to the filing date of this Annual
Report on Form 10-KSB, we have performed an evaluation of the effectiveness of
the design and operation of these controls under the supervision and with the
participation of our management, including our Chief Executive Officer. Based
upon that evaluation, the Chief Executive Officer has concluded that the
disclosure controls and procedures effectively alert management to material
information related to the Company in a manner which allows timely decisions
regarding required disclosures of such information. In the design and evaluation
of our disclosure controls and procedures, management has recognized that risks
of misstatements due to error, failures in compliance, or changes in conditions
are inherent in any cost-effective control system. Thus, management can provide
only reasonable assurance that its controls and procedures will achieve their
stated goals under all potential future conditions. There have been no
significant changes in our internal controls or in other factors that could
significantly affect these controls subsequent to the date of management's
evaluation.


                                     Part IV

                                   Signatures

     Pursuant to the  Requirements  of Section 13 or 15(d) of the Securities Act
of 1934,  the  registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorize.

TRIAD INDUSTRIES, INC.

By:_____________________
Linda Bryson, President


Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed by the persons on behalf of the registrant and in the capacities
and on the dates indicated:



Signature                Title                               Date


________________      President
Linda Bryson


________________      Sec. / Treas. / CFO
Michael W. Kelleher








                                       S-1



                        CERTIFICATION OF LINDA BRYSON

I, Linda Bryson, certify that:

(1) I have reviewed this annual report on Form 10-K of Triad Industries,Inc;

(2) Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

(3) Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

(4) The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     a) designed such disclosure controls and procedures to ensure that material
     information relating to the registrant, including its consolidated
     subsidiaries, is made known to us by others within those entities,
     particularly during the period in which this annual report is being
     prepared;

     b) evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of the date within 90 days prior to filing date of this
     annual report (the "Evaluation Date"); and

     c) presented in this annual report our conclusions about the effectiveness
     of the disclosure controls and procedures based on our evaluation as of the
     Evaluation Date;

(5) The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of registrant's board of directors (or persons performing the equivalent
function):

     a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

     b) any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

(6) The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent
to the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

                                        /s/ Linda Bryson
Date: April 10, 2003                   ---------------------
                                             Linda Bryson
                                             President





                         CERTIFICATION OF MICHAL KELLEHER


I, Michael Kelleher, certify that:

(1) I have reviewed this annual report on Form 10-K of Triad Industries, Inc.;

(2) Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

(3) Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

(4) The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     a) designed such disclosure controls and procedures to ensure that material
     information relating to the registrant, including its consolidated
     subsidiaries, is made known to us by others within those entities,
     particularly during the period in which this annual report is being
     prepared;

     b) evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of the date within 90 days prior to filing date of this
     annual report (the "Evaluation Date"); and

     c) presented in this annual report our conclusions about the effectiveness
     of the disclosure controls and procedures based on our evaluation as of the
     Evaluation Date;

(5) The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of registrant's board of directors (or persons performing the equivalent
function):

     a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

     b) any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

(6) The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent
to the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: April 10, 2003                       /s/ Michael Kelleher
                                              -----------------
                                               Michael Kelleher
                                               Chief Financial Officer
















EXHIBIT 99.1

                  SECTION 906 CERTIFICATION OF LINDA BRYSON


                        CERTIFICATION OF PERIODIC REPORT

      In connection with the Annual Report of Triad Industries,
Inc. (the "Company") on Form 10-K for the period ending December 31, 2002 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Linda Bryson, President of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1.) The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

         (2.) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Date: April 10, 2003                              By: /s/ Linda Bryson
                                                     -------------------
                                                    Linda Bryson
                                                       President


























                                  EXHIBIT 99.2

                   SECTION 906 CERTIFICATION OF MICHAEL KELLEHER


                        CERTIFICATION OF PERIODIC REPORT

      In connection with the Annual Report of Triad Industries,
Inc. (the "Company") on Form 10-K for the period ending December 31, 2002 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Michael Kelleher, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1.) The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

         (2.) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Date: April 10, 2003                                By: /s/ Michael Kelleher
                                                    -----------------
                                                          Michael Kelleher
                                                     Chief Financial Officer